Your session is about to expire
← Back to Search
Motion Perception Study for Vestibular Disorders
Study Summary
This trial looks at how well people can perceive movement, which may help researchers understand how aging and illness affects this ability.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have hearing loss in one or both ears.You are in overall good health.
- Group 1: Healthy subjects
- Group 2: Vestibular Disease patients
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could individuals younger than sixty years old qualify for this medical experiment?
"Applicants to this research must be aged 18 or older, but not beyond the age of 80."
Are there any available spaces in this trial for prospective participants?
"This clinical trial is actively seeking patient enrolment, with the first posting occuring on September 15th 2020 and last edited November 7th 2022. This information can be found at clinicaltrials.gov."
Do I meet the criteria for participating in this trial?
"To be eligible for this research, participants must have some form of vestibular disorder and meet the age requirement between 18 to 80 years old. In all, around 300 people are being accepted into the trial."
How many individuals are partaking in this clinical research experiment?
"Affirmative. According to the information provided on clinicaltrials.gov, this medical study is actively enrolling participants and was first posted on September 15th 2020. A total of 300 patients are needed from 1 site in order to complete the trial."
Share this study with friends
Copy Link
Messenger